During GLP-1 treatment , maintain regular contact with your healthcare team and report: Any new or worsening anxiety symptoms , including excessive worry, panic attacks, or physical anxiety symptoms Changes in mood , sleep patterns, or appetite beyond expected treatment effects Difficulty coping with side effects such as nausea, which may exacerbate anxiety Concerns about body image or eating behaviours as weight changes occur NICE guidance recommends holistic care for people with diabetes and obesity, recognising the importance of psychological wellbeing
GIP GIP is an incretin hormone and stands for gastric inhibitory polypeptide (renamed: glucosedependent insulinotropic polypeptide)
Abstract Recently, the role of the gut microbiota in diseases, including cardiovascular disease (CVD), has gained considerable research attention
47 Although lipid lowering by itself can lower vascular oxidative stress, 51,52 some of these antioxidant effects of statins appear to be cholesterol independent
Thirty-five-week-old MC4R mice were randomly divided into four groups with no blinding at one day before drug treatment, vehicle (saline, s.c.), semaglutide (0.5 mg/kg, s.c.), tirzepatide (0.05 mg/kg, s.c.), and retatrutide (0.05 mg/kg, s.c.) based on amounts of food intake from day 25 before drug treatment, body weight at day 2 before treatment, and fat mass at one day before treatment